close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Altimmune Inc Health care industry Viking Therapeutics Inc
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags US: News Business Pharmaceuticals
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Business News Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Pharmaceuticals Eli Lilly and Co Science
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Pharmaceuticals Eli Lilly and Co Health & Science
From CNBC.com News
Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell
Tags Meta Platforms Inc Investing Business News
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags United Airlines Holdings Inc Microsoft Corp Taiwan Semiconductor Manufacturing Co Ltd
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags Airlines Meta Platforms Inc Semiconductor device manufacturing
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Zealand Pharma A/S Roche Holding AG Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags UnitedHealth Group Inc Healthy Returns Merck & Co Inc
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Healthy Returns Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Biotech and Pharmaceuticals Health care industry Business News
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Investing Mad Money Markets
From CNBC.com News
Jim Cramer reviews 8 companies that could top $1 trillion in market cap
Tags Business News Markets Mad Money
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Breaking News: Politics Social issues UnitedHealth Group Inc
From CNBC.com News
Companies besides tech can reach megacap status, Jim Cramer says
Tags Markets Business News Mad Money
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Biotechnology Exchange/traded funds Stock markets
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Gilead Sciences Inc Healthy Returns CVS Health Corp
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags World Markets Daily Open Market Outlook
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Eli Lilly and Co Pharmaceuticals Asia Markets
From CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
Tags Breaking News: Business Biotechnology Companies
From CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
Tags US: News Eli Lilly and Co Investment strategy
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Altimmune Inc Health care industry Viking Therapeutics Inc
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
Tags U/S/ Markets Investing THE JM SMUCKDRN
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Novo Nordisk A/S Biotechnology Europe: Top News And Analysis
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Business News Novo Nordisk A/S Companies
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Pharmaceuticals Health care industry Eli Lilly and Co
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Zealand Pharma A/S Markets Europe News
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Biotech and Pharmaceuticals Eli Lilly and Co Labor economy
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Business News Novo Nordisk A/S CNBC Changemakers
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today